ADP interact with two different purinergic receptors on platelets, known as P2Y1 and P2Y12 Since 1997, plavix has been widely used to prevent and treat vascular thromboembolic diseases such as heart failure, stroke, and peripheral vascular diseases (23). Here, P2RY12 is linked to peripheral vascular disease.